Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 1/2024

03.05.2023 | Original Article

Prospective study of clinical, biochemical, and radiological characteristics of diabetic Charcot neuroarthropathy at a tertiary care centre

verfasst von: M. Aruna, Padala Ravi Kumar, Deepak Kumar Dash, Debasish Patro, T. Radhakrishna, Manas Ranjan Kundu, Sudhi Ranjan Pattanaik

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to assess demographic, clinical, biochemical, radiological profile and treatment response in diabetic patients with Charcot neuroarthropathy (CN).

Methods

This was a prospective study for screening of CN in patients with diabetes mellitus (DM) attending tertiary care centre over a period of 1 year. Acute CN (ACN) was diagnosed based on clinical features of local inflammation and temperature difference of > 2 °C from the normal foot after exclusion of other inflammatory causes. Chronic CN (CCN) was diagnosed when no inflammatory signs were present in a deformed foot with radiological findings supportive of diagnosis. In all these patients, demographic data, clinical features, biochemical investigations, X-ray, and MRI foot were done. The effect of offloading and customized foot wear in ACN, CCN were, respectively, studied over 1 year.

Results

Out of 5049 DM patients screened for CN over 1 year, 25 patients (0.49%) were diagnosed to have CN, of which 12 had ACN (0.23%) and 13 had CCN (0.26%). CN patients had significantly higher mean body mass index (BMI) (27.9 vs. 26.2 kg/m2; p = 0.02), longer duration of DM (12 vs. 9.6 years; p < 0.001), higher HbA1c (10.3 vs. 8.8%; p = 0.001), greater degree of peripheral neuropathy and retinopathy compared to controls. MRI could be able to detect 25% ACN cases where X-rays were non-diagnostic. The median duration of clinical resolution was 3 months in ACN patients.

Conclusions

High index of suspicion is required for diagnosing CN in DM patients.
Literatur
1.
Zurück zum Zitat Sohn MW, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009;32:816–21.CrossRefPubMedPubMedCentral Sohn MW, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009;32:816–21.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Chaudhary S, Bhansali A, Rastogi A. Mortality in Asian Indians with Charcot’s neuroarthropathy: a nested cohort prospective study. Acta Diabetol. 2019;56(12):1259–64.CrossRefPubMed Chaudhary S, Bhansali A, Rastogi A. Mortality in Asian Indians with Charcot’s neuroarthropathy: a nested cohort prospective study. Acta Diabetol. 2019;56(12):1259–64.CrossRefPubMed
4.
Zurück zum Zitat Durgia H, Sahoo J, Kamalanathan S, Palui R, Sridharan K, Raj H. Role of bisphosphonates in the management of acute Charcot foot. World J Diabetes. 2018;9:115–26.CrossRefPubMedPubMedCentral Durgia H, Sahoo J, Kamalanathan S, Palui R, Sridharan K, Raj H. Role of bisphosphonates in the management of acute Charcot foot. World J Diabetes. 2018;9:115–26.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor- kappa B ligand. Diabetologia. 2008;51(6):1035–40.CrossRefPubMedPubMedCentral Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor- kappa B ligand. Diabetologia. 2008;51(6):1035–40.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Larson SA, Burns PR. The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet Foot Ankle. 2012;3:12236.CrossRef Larson SA, Burns PR. The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet Foot Ankle. 2012;3:12236.CrossRef
7.
Zurück zum Zitat Sebastian AP, Dasgupta R, Jebasingh F, Saravanan B, Chandy B, Mahata KM, et al. Clinical features, radiological characteristics and offloading modalities in stage 0 acute Charcot’s neuroarthropathy - a single centre experience from South India. Diabetes Metab Syndr. 2019;13(2):1081–5.CrossRefPubMed Sebastian AP, Dasgupta R, Jebasingh F, Saravanan B, Chandy B, Mahata KM, et al. Clinical features, radiological characteristics and offloading modalities in stage 0 acute Charcot’s neuroarthropathy - a single centre experience from South India. Diabetes Metab Syndr. 2019;13(2):1081–5.CrossRefPubMed
8.
Zurück zum Zitat Rosenbaum AJ, DiPreta JA. Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res. 2015;473:1168–71.CrossRefPubMed Rosenbaum AJ, DiPreta JA. Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res. 2015;473:1168–71.CrossRefPubMed
9.
Zurück zum Zitat Griffiths DA, Kaminski MR. Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study. J Foot Ankle Res. 2021;14(1):44.CrossRefPubMedPubMedCentral Griffiths DA, Kaminski MR. Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study. J Foot Ankle Res. 2021;14(1):44.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: the Charcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991. p. 297–338. Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: the Charcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991. p. 297–338.
11.
Zurück zum Zitat Hastings MK, Johnson JE, Strube MJ et al. Progression of foot deformity in Charcot neuropathic osteoarthropathy. J Bone Joint Surg Am. 95:1206–1213. Hastings MK, Johnson JE, Strube MJ et al. Progression of foot deformity in Charcot neuropathic osteoarthropathy. J Bone Joint Surg Am. 95:1206–1213.
13.
Zurück zum Zitat Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003;17:571–80.CrossRefPubMed Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003;17:571–80.CrossRefPubMed
14.
Zurück zum Zitat Schoots IG, Slim FJ, Busch-Westbroek TE, Maas M. Neuroosteoarthropathy of the foot-radiologist: friend or foe? Semin Musculoskelet Radiol. 2010;14:365–76.CrossRefPubMed Schoots IG, Slim FJ, Busch-Westbroek TE, Maas M. Neuroosteoarthropathy of the foot-radiologist: friend or foe? Semin Musculoskelet Radiol. 2010;14:365–76.CrossRefPubMed
15.
Zurück zum Zitat Silvampatti S, Nagaraja HS, Rajasekaran S. Midfoot Charcot arthropathy: overview and surgical management. J Foot Ankle Surg (Asia-Pacific). 2016;3(2):97–106.CrossRef Silvampatti S, Nagaraja HS, Rajasekaran S. Midfoot Charcot arthropathy: overview and surgical management. J Foot Ankle Surg (Asia-Pacific). 2016;3(2):97–106.CrossRef
16.
Zurück zum Zitat Ergen FB, Sanverdi SE, Oznur A. Charcot foot in diabetes and an update on imaging. Diabetic Foot & Ankle. 2013;4:21884.CrossRef Ergen FB, Sanverdi SE, Oznur A. Charcot foot in diabetes and an update on imaging. Diabetic Foot & Ankle. 2013;4:21884.CrossRef
17.
Zurück zum Zitat Salini D, Harish K, Minnie P, Sundaram KR, Arun B, Sandya CJ, et al. Prevalence of Charcot arthropathy in Type 2 diabetes patients aged over 50 years with severe peripheral neuropathy: a retrospective study in a tertiary care South Indian hospital. Indian J Endocr Metab. 2018;22:107–11.CrossRef Salini D, Harish K, Minnie P, Sundaram KR, Arun B, Sandya CJ, et al. Prevalence of Charcot arthropathy in Type 2 diabetes patients aged over 50 years with severe peripheral neuropathy: a retrospective study in a tertiary care South Indian hospital. Indian J Endocr Metab. 2018;22:107–11.CrossRef
18.
Zurück zum Zitat Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med. 2008;121:1008–14.CrossRefPubMed Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med. 2008;121:1008–14.CrossRefPubMed
20.
Zurück zum Zitat Pitocco D, Ruotolo V, Caputo S, Mancini L, Collina CM, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28:1214–5.CrossRefPubMed Pitocco D, Ruotolo V, Caputo S, Mancini L, Collina CM, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28:1214–5.CrossRefPubMed
21.
Zurück zum Zitat Riddhi Dasgupta, Damien Cheema, Anna Cheema, Mruthyunjaya Mahesh D, Mary MahataKoyeli, Jyoti Panwar, et al. Clinical characteristics, foot-associated risk factors, offloading practices and radiological assessment in patients with type 2 diabetes mellitus and chronic Charcot’s neuroarthropathy: a case control study from India. J Global Diabet Clin Metab. 2017;2:13–5. Riddhi Dasgupta, Damien Cheema, Anna Cheema, Mruthyunjaya Mahesh D, Mary MahataKoyeli, Jyoti Panwar, et al. Clinical characteristics, foot-associated risk factors, offloading practices and radiological assessment in patients with type 2 diabetes mellitus and chronic Charcot’s neuroarthropathy: a case control study from India. J Global Diabet Clin Metab. 2017;2:13–5.
22.
Zurück zum Zitat Chantelau EA, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging-a review of 71 cases. Swiss Med Wkly. 2013; 29(7); 143:w13831. Chantelau EA, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging-a review of 71 cases. Swiss Med Wkly. 2013; 29(7); 143:w13831.
23.
Zurück zum Zitat Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, et al. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55(1):32–5.CrossRefPubMed Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, et al. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55(1):32–5.CrossRefPubMed
24.
Zurück zum Zitat Stark C, Murray T, Gooday C, Nunney I, Hutchinson R, Loveday D, et al. 5 year retrospective follow-up of new cases of Charcot neuroarthropathy-a single centre experience. Foot Ankle Surg. 2016;22(3):176–80.CrossRefPubMed Stark C, Murray T, Gooday C, Nunney I, Hutchinson R, Loveday D, et al. 5 year retrospective follow-up of new cases of Charcot neuroarthropathy-a single centre experience. Foot Ankle Surg. 2016;22(3):176–80.CrossRefPubMed
25.
Zurück zum Zitat Pinzur MS, Lio T, Posner M. Treatment of Eichenholtz stage I Charcot foot arthropathy with a weight bearing total contact cast. Foot Ankle Int. 2006;27(5):324–9.CrossRefPubMed Pinzur MS, Lio T, Posner M. Treatment of Eichenholtz stage I Charcot foot arthropathy with a weight bearing total contact cast. Foot Ankle Int. 2006;27(5):324–9.CrossRefPubMed
26.
Zurück zum Zitat de Souza LJ. Charcot arthropathy and immobilization in a weight-bearing total contact cast. J Bone Joint Surg Am. 2008;90(4):754–9.CrossRefPubMed de Souza LJ. Charcot arthropathy and immobilization in a weight-bearing total contact cast. J Bone Joint Surg Am. 2008;90(4):754–9.CrossRefPubMed
27.
Zurück zum Zitat Thewjitcharoen Y, Parksook W, Krittiyawong S, Porramatikul S, Sripatpong J, Mahaudomporn S, et al. A closer look at outcome of diabetic Charcot foot: Thailand’s perspective. Diabetes Res Clin Pract. 2014;1:S63.CrossRef Thewjitcharoen Y, Parksook W, Krittiyawong S, Porramatikul S, Sripatpong J, Mahaudomporn S, et al. A closer look at outcome of diabetic Charcot foot: Thailand’s perspective. Diabetes Res Clin Pract. 2014;1:S63.CrossRef
28.
Zurück zum Zitat Gooday C, Gray K, Game F, Woodburn J, Poland F, Hardeman W. Systematic review of techniques to monitor remission of acute Charcot neuroarthropathy in people with diabetes. Diabetes Metab Res Rev. 2020;36: e3328.CrossRefPubMed Gooday C, Gray K, Game F, Woodburn J, Poland F, Hardeman W. Systematic review of techniques to monitor remission of acute Charcot neuroarthropathy in people with diabetes. Diabetes Metab Res Rev. 2020;36: e3328.CrossRefPubMed
Metadaten
Titel
Prospective study of clinical, biochemical, and radiological characteristics of diabetic Charcot neuroarthropathy at a tertiary care centre
verfasst von
M. Aruna
Padala Ravi Kumar
Deepak Kumar Dash
Debasish Patro
T. Radhakrishna
Manas Ranjan Kundu
Sudhi Ranjan Pattanaik
Publikationsdatum
03.05.2023
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 1/2024
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-023-01199-z

Weitere Artikel der Ausgabe 1/2024

International Journal of Diabetes in Developing Countries 1/2024 Zur Ausgabe